Saxonov Serge 4
4 · 10x Genomics, Inc. · Filed Apr 16, 2026
Research Summary
AI-generated summary of this filing
10x Genomics (TXG) CEO Serge Saxonov Sells 5,000 Shares
What Happened
- Serge Saxonov, CEO of 10x Genomics, reported an open-market sale of 5,000 shares on April 14, 2026. The weighted average sale price was $24.56, with trade prices ranging from $24.49 to $24.70, for total proceeds of approximately $122,784. This was a sale (not a purchase), and such transactions are commonly routine dispositions.
Key Details
- Transaction date: 2026-04-14 (reported on Form 4 filed 2026-04-16)
- Transaction type/code: Open-market sale (S)
- Shares sold: 5,000; weighted average price: $24.56; price range: $24.49–$24.70; proceeds ≈ $122,784
- Ownership after transaction: Not specified in the provided filing excerpt
- Notable footnotes:
- F1: Sale executed pursuant to a Rule 10b5-1 trading plan adopted Nov 29, 2025
- F2: Multiple trades; Reporting Person can provide breakdown of shares sold at each price on request
- F3–F5: Some shares referenced are held in trusts (Andromeda Trust, Y/S Descendants' Trust, Y/S Pot Trust) for which Saxonov serves as trustee
- Timeliness: Filed within the typical two-business-day window (not indicated as late)
Context
- The sale was executed under a pre-established 10b5-1 plan, which is designed to allow insiders to sell shares according to a predetermined schedule and reduce concerns about trading on inside information. Sales are generally less informative than purchases about an insider’s view of the company; this entry documents a routine disposition rather than an acquisition.
Insider Transaction Report
Form 4
Saxonov Serge
DirectorChief Executive Officer
Transactions
- Sale
Class A Common Stock
[F1][F2]2026-04-14$24.56/sh−5,000$122,784→ 1,167,273 total
Holdings
- 27(indirect: See footnote)
Class A Common Stock
[F3] - 213,250(indirect: See footnote)
Class A Common Stock
[F4] - 71,644(indirect: See footnote)
Class A Common Stock
[F5]
Footnotes (5)
- [F1]The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $24.49 to $24.70, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
- [F4]The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
- [F5]The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
Signature
/s/ Randy Wu, as Attorney-in-Fact for Serge Saxonov|2026-04-16